Health
Johnson & Johnson vaccine: Why it’s worth the minuscule risk – Inverse
The benefits for the one-dose Covid-19 vaccine outweigh the risks.
The CDC and the FDA lifted the pause
on the Johnson & Johnson Covid-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots.
Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue.
Dr. William Petri, an infectious disease physician and immunologist at the University of Virginia School of Medicine, explains…
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM